HYPERION DEFI, INC. (HYPD) Gross Margin
- Gross margin · 12 months: Value 78.35%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 78.35% | Gross profit / revenue. Period ending 2026-06-30. $1.10M ÷ $1.40M × 100 ≈ 78.35% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 1.10M USD | Gross Profit |
| Revenue | 1.40M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $1.10M | $1.40M | (m) | 78.35% |
| 2026-03-31 | $739.76K | $1.04M | (m) | 70.93% |
| 2025-12-31 | $510.17K | $813.46K | (m) | 62.72% |
| 2025-09-30 | $-2.76M | $345.32K | (m) | -798.12% |
| 2025-06-30 | $-3.19M | $44.44K | (m) | -7177.30% |
| 2025-03-31 | $-3.66M | $67.06K | (m) | -5453.36% |
| 2024-12-31 | $-3.87M | $57.34K | (m) | -6749.50% |
| 2024-09-30 | (m) | $31.83K | (m) | (m) |
| 2024-06-30 | (m) | $31.41K | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $3.79K | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) |
| 2022-09-30 | $10.00M | $10.00M | (m) | 100.00% |
| 2022-06-30 | $10.00M | $10.00M | (m) | 100.00% |
| 2022-03-31 | $11.20M | $12.00M | (m) | 93.33% |
| 2021-12-31 | $12.40M | $14.00M | (m) | 88.57% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | $3.60M | $6.00M | (m) | 60.00% |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $1.20M | $2.00M | (m) | 60.00% |
| 2020-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |